High-Throughput Screening (HTS)
Enabling researchers to conduct carefully planned
drug discovery research that would otherwise be prohibitively expensive for single laboratories.
The Cancer Center's High-Throughput Screening (HTS) Shared Resource allows Cancer Center members to use the techniques of high-throughput screening of compounds or genomic siRNA libraries. The compounds identified in such experiments can be used as research tools to understand the complex molecular relationships that cause or prevent cancer as well as possible candidates for eventual drug development. The genes identified in HTS experiments may become eventual targets for compound screens leading to novel therapeutics.